Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Robert P. McMahon, PhD
JCP
Original Research
Clozapine Use in Patients with Benign Neutropenia
November 23, 2016
Is clozapine safe for patients with benign neutropenia? Many patients with lower than normal absolute neutrophil count do not qualify for clozapine therapy or are at risk of having...
Charles M. Richardson
,
Erica A. Davis
,
Gopal R. Vyas
, et al
PCC
Letter to the Editor
Substance Use and Cannabis Withdrawal
September 1, 2016
Cannabis withdrawal symptoms are clinically significant because they may act as negative reinforcement for relapse to cannabis use. Here, the authors present data on psychoactive substance use before and...
Maju Mathew Koola
,
Deanna L. Kelly
,
Robert P. McMahon
, et al
JCP
Original Research
Participants With Schizophrenia Retain the Information Necessary for Informed Consent During Clinical Trials
June 15, 2013
Bernard A. Fischer
,
Robert P. McMahon
,
Walter A. Meyer
, et al
JCP
Original Research
Bupropion Sustained Release Added to Group Support for Smoking Cessation in Schizophrenia: A New Randomized Trial and a Meta-Analysis
April 5, 2011
Elaine Weiner
,
M. Patricia Ball
,
Alison S. Buchholz
, et al
JCP
Original Research
Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine: A Retrospective Cohort Study
January 12, 2010
Deanna L. Kelly
,
Robert P. McMahon
,
Fang Liu
, et al
JCP
Original Research
A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia
April 7, 2009
Deanna L. Kelly
,
Robert W. Buchanan
,
Douglas L. Boggs
, et al
